Rosiglitazone augments antioxidant response in the human trophoblast and prevents apoptosis()

Insufficient perfusion of the trophoblast by maternal blood is associated with an increased generation of reactive oxygen species and complications of the placenta. In this study, we first examined whether rosiglitazone, an agonist of the peroxisome proliferator-activated receptor-γ (PPARγ), protect...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Reprod
Autors principals: Kohan-Ghadr, Hamid-Reza, Kilburn, Brian A, Kadam, Leena, Johnson, Eugenia, Kolb, Bradley L, Rodriguez-Kovacs, Javier, Hertz, Michael, Armant, D Randall, Drewlo, Sascha
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6500927/
https://ncbi.nlm.nih.gov/pubmed/30137220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/biolre/ioy186
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars